Albemarle to increase prices of dibromomethane and bromochloromethane

    Albemarle to increase prices of dibromomethane and bromochloromethane

PR Newswire

BATON ROUGE, La., May 31, 2013

BATON ROUGE, La., May 31, 2013 /PRNewswire/ --Albemarle Corporation (NYSE:
ALB), a global developer, manufacturer and marketer of highly engineered
specialty chemicals, announced today that it will increase global prices for
dibromomethane (also referred to as DBM, methylene dibromide, or MDB) and
bromochloromethane (also referred to as BCM) by 25%. The price increases are
effective immediately, or as contracts allow.


Albemarle's dibromomethane and bromochloromethane products are part of the
company's Performance Chemicals division within the Fine Chemistry business
segment and are primarily used in agricultural products.

About Albemarle
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading
global developer, manufacturer, and marketer of highly-engineered specialty
chemicals for consumer electronics, petroleum refining, utilities, packaging,
construction, automotive/transportation, pharmaceuticals, crop protection,
food-safety and custom chemistry services. Albemarle is committed to global
sustainability and is advancing its eco-practices and solutions in its three
business segments, Polymer Solutions, Catalysts and Fine Chemistry. Corporate
Responsibility Magazine selected Albemarle to its prestigious "100 Best
Corporate Citizens" list for 2010 and 2011. Albemarle employs approximately
4,000 people and serves customers in approximately 100 countries. Albemarle
regularly posts information to, including notification of
events, news, financial performance, investor presentations and webcasts,
Regulation G reconciliations, SEC filings, and other information regarding the
company, its businesses and the markets we serve.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of
1995: Statements in this press release regarding Albemarle Corporation's
business that are not historical facts are "forward-looking statements" that
involve risks and uncertainties. For a discussion of such risks and
uncertainties, which could cause actual results to differ from those contained
in the forward-looking statements, see "Risk Factors" in the Company's Annual
Report on Form 10-K.

SOURCE Albemarle Corporation

Contact: Media Contact: Ashley Mendoza, (225) 388-7137,; Investor Relations Contact: Lorin Crenshaw,
(225) 388-7322,
Press spacebar to pause and continue. Press esc to stop.